Immediate Impact
52 standout
Citing Papers
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
2025 Standout
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
2025 Standout
Works of Francesca Ligorio being referenced
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial
2022
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Francesca Ligorio | 263 | 125 | 99 | 150 | 31 | 466 | |
| Faruk Taş | 231 | 122 | 97 | 153 | 44 | 569 | |
| Emma Zattarin | 265 | 110 | 160 | 102 | 41 | 452 | |
| Lucy A. Coupland | 195 | 64 | 73 | 216 | 37 | 563 | |
| M. Coviello | 110 | 90 | 56 | 98 | 24 | 433 | |
| Claire Bléchet | 136 | 161 | 53 | 192 | 26 | 462 | |
| Murat Serilmez | 232 | 102 | 90 | 197 | 34 | 558 | |
| Riccardo Lobefaro | 248 | 129 | 104 | 122 | 31 | 454 | |
| Osamu Nagakawa | 196 | 123 | 178 | 180 | 33 | 566 | |
| Anne Winther‐Larsen | 174 | 164 | 221 | 112 | 39 | 482 | |
| Norisuke Shibuya | 250 | 124 | 70 | 75 | 26 | 433 |
All Works
Login with ORCID to disown or claim papers
Loading papers...